|Printable version||E-mail this to a friend|
New guidance: infant and follow-on formula from protein hydrolysates
New guidance published by EFSA will assist applicants in preparing and presenting dossiers for authorisation of infant and/or follow-on formulae manufactured from protein hydrolysates. It will also help applicants in preparing dossiers to assess a product’s efficacy in reducing the risk of infants becoming allergic to milk proteins.
Regulatory rules dating back to 2006 were revised in 2016. The revision was based on scientific advice by EFSA on the need to establish the safety and suitability of each protein hydrolysate used in the manufacture of formula. EFSA had also advised that clinical studies be conducted to demonstrate a formula’s potential to reduce the risk of infants developing allergy to milk proteins.
What kind of data do applicants need to submit?
EFSA’s technical and scientific guidance details the type of data and information applicants need to provide. The required information should include:
- Characterisation of the hydrolysed infant or follow-on formulae, including a description of the manufacturing process;
- Information about the nutritional safety and suitability of the formula, including information on the history of use; and/or
- Information on the product’s efficacy in reducing the risk of developing an allergy to milk proteins.
The guidance presents a common format for the organisation of the information applicants need to provide. A well-structured application will help the Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA Panel) to carry out its evaluation and deliver its scientific advice effectively and consistently.
Prior to finalising the guidance, EFSA presented the document to the public and invited feedback. EFSA received and considered over 80 comments from seven interested parties including a governmental organisation, food business operators and industry associations.
What is protein hydrolysate formula?
Formulas manufactured from protein hydrolysates contain protein which has been partially broken down to different degrees with the aim of reducing the risk of infants developing allergies.
Latest News from
Adoption of new rules to block tax avoidance30/05/2017 12:05:00
The EC has welcomed the formal adoption of new EU rules to prevent tax avoidance via non-EU countries.
First meeting of the Digital Clearinghouse30/05/2017 11:36:00
This is the culmination of several years of important discussions about how to respond to the digital challenge. Regulatory bodies have the necessary tools to address questions of concentration of market and informational power - and we have been considering how to use these tools in a smarter way.
Publication of Foreign Exchange Global Code of Conduct26/05/2017 13:10:00
The European System of Central Banks (ESCB) welcomes the publication of the Foreign Exchange Global Code of Conduct (Code) and related adherence mechanisms material.
Commission debates future of European defence25/05/2017 16:10:00
Feeding into the discussion on the future direction of the EU at 27, the Commission has held an orientation debate on the future of European defence.